Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
Journal of the National Cancer Institute|June 1, 1981
Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patientsE M Hersh, S G Murphy, J R Quesada, et al.
Cancer|January 15, 1982
Antibody-dependent cell-mediated cytotoxicity in human cancer: characterization of patient leukocyte activity and treatment effectsE V Hersh, S G Murphy, J U Gutterman, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancerJ U Gutterman, G M Mavligit, G Blumenshein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferonA Rios, P W Mansell, G R Newell, et al.
Science (New York, N.Y.)|September 22, 1972
Antigen solubilized from human leukemia: lymphocyte stimulationJ U Gutterman, G Mavligit, K B McCredie, et al.
Cancer Research|November 1, 1972
Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosisJ U Gutterman, E M Hersh, K B McCredie, et al.
Blood|July 1, 1987
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaR Kurzrock, W S Kloetzer, M Talpaz, et al.
Cancer Research|July 1, 1983
Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992)S W Hall, J Friedman, S S Legha, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignanciesE A Obbens, L G Feun, M E Leavens, et al.
Journal of Biological Response Modifiers|June 1, 1989
Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinomaI W Dimery, C Jacobs, A Tseng, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
Journal of the National Cancer Institute|June 1, 1981
Effect of immunotherapy with Corynebacterium parvum and methanol extraction residue of BCG administered intravenously on host defense function in cancer patientsE M Hersh, S G Murphy, J R Quesada, et al.
Cancer|January 15, 1982
Antibody-dependent cell-mediated cytotoxicity in human cancer: characterization of patient leukocyte activity and treatment effectsE V Hersh, S G Murphy, J U Gutterman, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancerJ U Gutterman, G M Mavligit, G Blumenshein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1985
Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferonA Rios, P W Mansell, G R Newell, et al.
Science (New York, N.Y.)|September 22, 1972
Antigen solubilized from human leukemia: lymphocyte stimulationJ U Gutterman, G Mavligit, K B McCredie, et al.
Cancer Research|November 1, 1972
Lymphocyte blastogenesis to human leukemia cells and their relationship to serum factors, immunocompetence, and prognosisJ U Gutterman, E M Hersh, K B McCredie, et al.
Blood|July 1, 1987
Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaR Kurzrock, W S Kloetzer, M Talpaz, et al.
Cancer Research|July 1, 1983
Human pharmacokinetics of a new acridine derivative, 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992)S W Hall, J Friedman, S S Legha, et al.
Journal of Neuro-Oncology|January 1, 1985
Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignanciesE A Obbens, L G Feun, M E Leavens, et al.
Journal of Biological Response Modifiers|June 1, 1989
Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinomaI W Dimery, C Jacobs, A Tseng, et al.
Pageof 34